CRP and hyperlipidemia: In patients with type 1 DM, atherogenic hyperlipidemia was associated with impaired renal function as assessed by decreased GFR, increased microalbuminuria and serum creatinine concentration, and chronic subclinical inflammation (evidenced by the increased ferritin, ESR and CRP).